Skip to main content
. 2020 Jun 11;295(32):11099–11117. doi: 10.1074/jbc.REV120.011833

Table 1.

Hsp90 post-translational modifications, identified modifying enzymes, and functional consequences

Identified modification sites in Hsp90 are shown. Conservation between α and β isoforms is highlighted. Further indication of other species in which residues were found as well as other modifications that particular sites are subject to is as follows: boldface type, identified in that isoform; *, identified in Hsp82; †, identified in zebrafish Hsp90a1; §, identified in Candida albicans; a, acetylation; n, nitration; p, phosphorylation; s, SUMOylation; sc, succinylation; u, ubiquitination; g, glycation; o, O-GlcNAcylation; m, methylation; c, citrullination; sn, S-nitrosylation; t, thiocarbamlyation; ↑, binding increased (increased ATPase or increased inhibitor binding or sensitivity); ↓, binding decreased (decreased ATPase or decreased inhibitor binding or sensitivity); nc, no change; NA, not applicable/not conserved; no entry provided in the table if not determined or examined.

PTM Residue
Enzyme
Small-molecule binding
References
Hsp90α Hsp90β Compound ATP Inhibitors
Serine/threonine phosphorylation T5 NA ATM, DNA-PK 5762
T7 NA ATM, DNA-PK 5763
T36 (*,†) T31 CK2 6466
S63 S58 CK2 6769
T65 T60 CK2 68, 70
S68 S63 CK2 68
S72 S67 CK2 68
T88 T83 PKA 69, 71, 72
T90 T85 PKA 7276
S113 S108 (*) HopBF1 77
T115 T110 Mps1, Cdc14, PKCγ 78, 79
S164 S159 Cdc7-Dbf4 80, 81
S211 S206 PKA/PKG 82, 83
S231 S226 CK2, PP5 55, 8489
S263 S255 CK2, B-Raf, PP5 55, 8492
N373 S365 CK2 83, 93
S399 (*) S391 67, 9496
T425 S417 PKCγ 79
S460 (o) S452 (o) PKA 82
S505 (*) S497 69, 94
S595 S587 Mitogen-activated protein kinase 12 (p38γ) 9799
T603 T595 PKCγ nc 79, 99
S623 (*) S615 94, 100, 101
T624 T616 102, 103
M625 (*) M617 94
T725 A717 CK2, CK1, GSK3β 104, 105
S726 S718 CK2, CK1, GSK3β 104, 105
Tyrosine phosphorylation Y38 (*,n) Y33 (n) Swe1 99, 106
Y197 Y192 v-Src, Yes 107112
Y309 Y301 c-Src 110, 113, 114
Y313 Y305 42, 69, 107, 115
Y627 (*) Y619 69, 107, 116, 117
Acetylation K41 (§,u) K36 (u) 118120
K69 (u) K64 (u) HAT p300 101, 121124
K74 (u,g) K69 (u) 97, 99
K100 (u,g) K95 HAT p300 121
K292 (u) K284 (u) HAT p300 121, 124
K294 (†,§,u) K286 (u) HDAC6 65, 118, 119, 125129
K327 (u) K319 (u) HAT p300 99, 121
K407 (u) K399 (u) 124, 130
K419 (u) K411 130, 131
K478 (u,g) S470 HAT p300 121
K546 (u,g,sc) K538 (u,sc) HAT p300 121, 131
K558 (u) K550 HAT p300 121
Monomethylation K209 (†,u) K204 SMYD2 65, 132
K539 K531 (a,u) SMYD2 133
K582 K574 (a,u) SMYD2 133
K615 (*,†,a,u) K607 SMYD2 65, 132, 134136
Thiocarbamylation C529 C521 6-HITC-ME 137
C597 (sn) C589 (sn) STCA 138
S-Nitrosylation C597 (t) C589 (t) Nitric oxide 139, 140
SUMOylation K191 (a,u) K186 SUMO-1 141
K559 (u) K551 SUMO peptidase sentrin/SUMO-specific protease 2 (SENP2) 142
Ubiquitination K112 (g) K107 CHIP 143145
K209 (m) K204 (a) CHIP 143, 144, 146
K224 (a) K219 (a) CHIP 143, 144, 146
K283 (a,g) K275 (a) CHIP 143, 144, 146
K292 (a) K284 (a) CHIP 143, 144, 146
R355 K347 (a,m,sc) CHIP 144
K407 (a) K399 (a) CHIP 143, 144, 146
K485 (a) K477 (a) CHIP 143, 144
K489 (a,m,sc) K481 (a,sc) CHIP 143, 144, 146
K546 (a,g,sc) K538 (a,sc) CHIP 143145
K558 (a) K550 CHIP 143, 144
K615 (a,m) K607 (a) CHIP 143, 144, 147
K631 (a,sc) K623 (a,sc) CHIP 143, 144, 148
Nitration Y38 (p) Y33 (p) 149, 150
Y61 (p) Y56 (p) 149
O-GlcNAcylation S442 (p) S434 (p) 151
S460 (p) S452 (p) 151